These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4670494)

  • 1. Susceptibility of mycobacteria to rifampin.
    Woodley CL; Kilburn JO; David HL; Silcox VA
    Antimicrob Agents Chemother; 1972 Oct; 2(4):245-9. PubMed ID: 4670494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of atypical mycobacteria to rifampin.
    Molavi A; Weinstein L
    Appl Microbiol; 1971 Jul; 22(1):23-5. PubMed ID: 5111305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
    Yates MD; Collins CH
    Tubercle; 1981 Jun; 62(2):117-21. PubMed ID: 7303160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs?
    Rastogi N; Goh KS; Guillou N; Labrousse V
    Zentralbl Bakteriol; 1992 Dec; 277(4):474-84. PubMed ID: 1303690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rifampin-resistance in pathogenic mycobacteria.
    Williams DL; Waguespack C; Eisenach K; Crawford JT; Portaels F; Salfinger M; Nolan CM; Abe C; Sticht-Groh V; Gillis TP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2380-6. PubMed ID: 7840574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species.
    Collins FM
    J Appl Bacteriol; 1986 Sep; 61(3):247-51. PubMed ID: 3096931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1988 Dec; 22(6):857-61. PubMed ID: 3243734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
    Tsukamura M
    Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.
    Chien JY; Chang TC; Chiu WY; Yu CJ; Hsueh PR
    PLoS One; 2015; 10(5):e0125016. PubMed ID: 25938668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Haas H; Michel J; Sacks TG
    Chemotherapy; 1982; 28(1):1-5. PubMed ID: 7056128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of purified protein derivative extracts from cultures of mycobacteria killed by phenol.
    Choi CS; Frost AJ; Francis J
    Res Vet Sci; 1981 Nov; 31(3):284-8. PubMed ID: 7342222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry.
    Bownds SE; Kurzynski TA; Norden MA; Dufek JL; Schell RF
    J Clin Microbiol; 1996 Jun; 34(6):1386-90. PubMed ID: 8735085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
    Ho YI; Chan CY; Cheng AF
    J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical classification of 280 strains of slowly growing mycobacteria. Proposal of Mycobacterium tuberculosis series, Mycobacterium avium series, and Mycobacterium nonchromogenicum series.
    Tsukamura M
    Microbiol Immunol; 1983; 27(4):315-34. PubMed ID: 6412041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.